Continuous bioprocessing market to grow at 22.4% CAGR, reaching $599M by 2028, revolutionizing pharma manufacturing with efficiency, quality, and innovation.
In I&I diseases space, drug development which is powered by artificial intelligence is making small molecules more attractive as compared to biologics.
Second consecutive Best Clinical Trial Supplier Award for Data Management & Analytics for Oracle Life Sciences at the Asia Pacific Biopharma Excellence Awards.
In order to further expand its portfolio in the field of oncology, Taiho Pharmaceutical from Japan has bought Araris Biotech from Switzerland for $740 million.
Advanced Instruments to acquire Nova Biomedical to help establishing an analytical instruments platform enhancing biopharma & clinical market capacities.
AstraZeneca pursues acquisition of EsoBiotec for $1 billion to advance cell therapies portfolio, focusing on innovative in vivo therapies via EnaBL platform.
